Compare CDW Corp. (CDW) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CDW Corp. vs Invesco Ltd. — how do they compare? CDW Corp. trades at $135 (market cap $16.92B), while Invesco Ltd. trades at $31.16 (market cap $13.85B). The key difference: CDW Corp. is the larger of the two by market cap, and Invesco Ltd. pays the higher dividend (2.74%). Which is the better fit depends on your goals.
| CDW | IVZ | |
|---|---|---|
Market Cap | $16.92B | $13.85B |
Sector | Technology | Financials |
52-Week High | $170.77 | $32.01 |
52-Week Low | $99.30 | $20.67 |
Enterprise Value | $22.52B | $24.01B |
Dividend Yield | 1.86% | 2.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
